Bench2Market Talks: FDA Strategy

Learn about the differing regulatory pathways for devices, therapeutics, diagnostics, and digital health technologies. We’ll review the many variables in cost and timeline and what they mean to you and your technology. Come ready with questions for featured speaker, Richard diMonda.   Register here http://bit.ly/FDA_Strategy. 

Speaker, Richard diMonda, BEE, MSBME, MBA, brings over 30 years of medical device commercialization experience, from a variety of public and private medical companies, to new medical device and Health IT ventures. He has executive management as well as hands-on experience with regulatory, clinical research, reimbursement, product management and marketing.

This event is the sixth session in the Bench2Market talks series which was created to provide commercialization guidance to the university research community. For more details on the series and to view the full schedule visit https://biolocity.gatech.edu/bench2market/.